Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Sales (2021 - 2025)

Oncology Institute (TOI) has disclosed Return on Sales for 5 consecutive years, with 0.12% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 4.0% year-over-year to 0.12%, compared with a TTM value of 0.14% through Sep 2025, up 4.0%, and an annual FY2024 reading of 0.16%, up 9.0% over the prior year.
  • Return on Sales was 0.12% for Q3 2025 at Oncology Institute, up from 0.14% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.35% in Q1 2022 and bottomed at 0.39% in Q1 2023.
  • Average Return on Sales over 5 years is 0.12%, with a median of 0.15% recorded in 2022.
  • The sharpest move saw Return on Sales skyrocketed 37bps in 2022, then tumbled -74bps in 2023.
  • Year by year, Return on Sales stood at 0.19% in 2021, then rose by 21bps to 0.15% in 2022, then crashed by -42bps to 0.22% in 2023, then skyrocketed by 40bps to 0.13% in 2024, then grew by 8bps to 0.12% in 2025.
  • Business Quant data shows Return on Sales for TOI at 0.12% in Q3 2025, 0.14% in Q2 2025, and 0.19% in Q1 2025.